Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
Authors:
- P. BalermpasPBP. Balermpas
- A. LingeALA. Linge
- F. LohausFLF. Lohaus
- M. KrauseMKM. Krause
- 1 July 2019
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 116, 67-76
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Deutschen Konsortium für Translationale Krebsforschung
This publication has 32 references indexed in Scilit:
- Genomic correlates of response to CTLA-4 blockade in metastatic melanomaScience, 2015
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience, 2015
- Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalenceEuropean Journal of Cancer, 2015
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine, 2014
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced SenescenceClinical Cancer Research, 2012
- Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Chromosomal changes characterize head and neck cancer with poor prognosisJournal of Molecular Medicine, 2008